Financiere Des Professionnels Fonds D,Investissement Inc. Biogen Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.74 Trillion
- Q3 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 1,646 shares of BIIB stock, worth $253,928. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,646Holding current value
$253,928% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,039Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.67 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.44 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.24 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.15 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$740 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...